by Jonathan Darabos | Feb 2, 2022 | Publications
202620252024202320222021 Molecular characterization of humanized APOE mouse models reveals source and genotype dependent differences - Molecular Neurodegeneration Click Here for Paper Estimating the baseline age when longitudinal changes in biomarkers accelerate - BMC...
by Jonathan Darabos | Feb 2, 2022 | Publications
A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Gallardo, G., Schlüter, O. M., & Südhof, T. C. (2008). Nature neuroscience, 11(3), 301308. α-Synuclein Interacts with Lipoproteins in Plasma. Emamzadeh, F. N., &...
by Jonathan Darabos | Feb 2, 2022 | Publications
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Peila, R., Rodriguez, B. L., Launer, L. J., & Honolulu-Asia Aging Study (2002). Diabetes, 51(4), 12561262. The association between apolipoprotein E gene...
by Jonathan Darabos | Feb 2, 2022 | Publications
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Robinson, J. L., Lee, E. B., Xie, S. X., Rennert, L., Suh, E., Bredenberg, C., Caswell, C., Van Deerlin, V. M., Yan, N., Yousef, A., Hurtig, H. I., Siderowf, A.,...
by Jonathan Darabos | Feb 2, 2022 | Publications
Coming...
